Status:

RECRUITING

The Longevity Genes in Founder Populations Project

Lead Sponsor:

Albert Einstein College of Medicine

Collaborating Sponsors:

National Institute on Aging (NIA)

American Federation for Aging Research

Conditions:

Extreme Longevity

Eligibility:

All Genders

65+ years

Brief Summary

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging;...

Eligibility Criteria

Inclusion

  • Ashkenazi Jewish, age 95+,
  • Offspring of person age 95+,
  • Offspring of parents who died age 70 or younger.

Exclusion

  • Non-Ashkenazis

Key Trial Info

Start Date :

July 1 1998

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2032

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT00707694

Start Date

July 1 1998

End Date

December 1 2032

Last Update

January 2 2026

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Private Homes

New York, New York, United States

2

Hebrew Home Riverdale

Riverdale, New York, United States, 10471